Board Directors

Appointed December 2018 - term of office started 1 April 2019

Sir Jonathan is Chair of Oxford University Hospitals NHS Foundation Trust and Chair of the Integrated Assurance Committee.

He is Professor of Healthcare Law at University College London (UCL) and co-Chair of the Moral and Ethical Advisory Group in the Department of Health and Social Care.

Sir Jonathan served on local NHS boards in Hampshire and the Isle of Wight for more than 20 years up to March 2013 - including being the Chair of a group of primary care trusts, a strategic health authority and two provider trusts - and was a member of the panel of advisers to the Morecambe Bay Investigation, which reported in 2015. He is also a past Chair of the Health Research Authority, the Advisory Committee on Clinical Excellence Awards, the Nuffield Council on Bioethics and the Human Genetics Commission.

In 2020 he chaired the Ethics Advisory Board to NHSx on the development of a COVID-19 contact tracing app. In 2021 he co-chaired the independent review into the legal, clinical and ethical aspects of the cosmetic procedure hymenoplasty.

Sir Jonathan was awarded a knighthood in the 2019 New Year Honours List for Services to Bioethics and Healthcare Law.

Appointed March 2025

Simon was appointed as Deputy Chief Executive Officer in May 2024 and joined the Trust on 30 September 2024 from University Hospitals of Derby and Burton NHS Foundation Trust where he was Chief Finance Officer and Deputy Chief Executive.

Simon formerly held roles at Board level in a number of NHS organisations, and throughout his career has worked across different sectors and health communities within the NHS.

In his role as Deputy Chief Executive Officer, Simon focused on areas including strategy, planning, improvement, innovation, and delivery. He also deputises for the Chief Executive Officer as and when required.

Simon was appointed as Acting Chief Executive Officer in March 2025 when Professor Meghana Pandit was appointed as Co-National Medical Director – Secondary Care in the NHS Transformation Executive Team which will help to lead NHS England’s transition into the Department of Health and Social Care.

Simon took up the post of Acting Chief Executive Officer on 1 April 2025 when Meghana began her 18-month secondment.

Appointed March 2023 (fixed term from 1 July 2022 to 28 February 2023 and substantive from 1 March 2023) – on secondment as Co-National Medical Director – Secondary Care from 1 April 2025.

Meghana trained in Obstetrics and Gynaecology in the Oxford Deanery and was Visiting Lecturer in Urogynaecology at University of Michigan, Ann Arbor, USA.

Meghana was Consultant Obstetrician and Gynaecologist, Clinical Director and then Divisional Director at Milton Keynes before joining University Hospitals Coventry and Warwickshire NHS Trust (UHCW) where she was Chief Medical Officer from May 2012 to December 2018 and Deputy Chief Executive from 2014.

Meghana completed an MBA from Oxford Brookes University and the Innovating Health for Tomorrow Programme at INSEAD, Fontainebleau. She was awarded the Founding Senior Fellowship of the Faculty of Medical Management and Leadership and is an Honorary Professor at Warwick University. She is Associate Fellow at Green Templeton College, University of Oxford.

As Chief Medical Officer at UHCW, Meghana led the development of clinical strategy and had responsibility for Clinical Quality, Risk, Medical Education, Research and Development, and Legal Services. She was Responsible Officer for over 500 doctors and undertook clinical office based Gynaecology.

As Chief Medical Officer at Oxford University Hospitals, Meghana had responsibility for Clinical Safety and Outcomes, Infection Prevention and Control, Medical Education and Research and Development. She was also Responsible Officer for over 1,000 doctors.

She was appointed as Chief Executive Officer (fixed term) of Oxford University Hospitals from 1 July 2022, and appointed as Chief Executive Officer (permanent) in February 2023.

Meghana has been appointed as Co-National Medical Director – Secondary Care in the NHS Transformation Executive Team which will help to lead NHS England’s transition into the Department of Health and Social Care. She took up this important national leadership role on an 18-month secondment with effect from 1 April 2025.

Meghana continues her association with Warwick University.

Appointed October 2019 (current term ends October 2025)

Sarah has extensive Board experience in plc, private and mutual entities focusing on operational property management and real estate development.

Her current portfolio combines a mix of non-executive, consulting and executive roles. Her advisory business supports landowners to deliver long term value by creating visionary places which enhance their operating activities.

Sarah is a Chartered Accountant and was Joint Chief Executive and Finance Director at Newbury Racecourse plc for 15 years. She led the redevelopment of the racecourse, creating a new community of 1,500 homes with the racecourse at its core. She was subsequently Chief Operating Officer for the Meyrick Group, a complex multi-site private property group with commercial, leisure and residential interests.

She was a Non-Executive Director at Newbury Building Society, one of the largest shared ownership lenders in the UK, and she co-founded Modulous, a construction technology platform focused on transforming the design and delivery of sustainable, affordable homes.

Appointed September 2023 (current term ends September 2026)

Paul Dean is Chair of the Audit Committee

Paul Dean lives in West Oxfordshire and is a Trustee of the Oxford Trust, which is an independent charitable trust whose mission is to encourage the pursuit of science.

Paul is a chartered management accountant with extensive Audit Chair and Chief Finance Officer experience gained in a range of multi-national companies.

He has worked in both private equity and PLC environments, including FTSE 100 and FTSE 250 companies.

Appointed December 2023 (current term ends November 2026)

Claire Feehily lives in Gloucestershire and is Vice-Chair of the Brandon Trust, which provides learning disability services in Oxfordshire.

She is a qualified accountant with extensive experience gained in a range of executive, non-executive and trustee board positions.

Claire is a former Chair of Healthwatch Gloucestershire and was also a Non-Executive Director and Audit Committee Chair at Gloucestershire Hospitals NHS Foundation Trust until Summer 2023 before she joined the Oxford University Hospitals NHS Foundation Trust Board.

Appointed May 2019 (current term ends April 2025)

Claire Flint is Chair of the Remuneration and Appointments Committee

Claire has a portfolio career consisting of a number of non-executive roles. She is a Non-Executive Director and Remuneration Committee Chair at AWE. She is the Senior Independent Director at National Nuclear Laboratory and chairs their Remuneration Committee.

Claire was previously Group Human Resources and Brand Director at Oxford Instruments plc, a leading international provider of hi-tech tools, systems and products, where she served on the Management Board for more than ten years.

Prior to this she held a number of senior HR roles including with Diageo, Bass and NatWest.

Appointed October 2019 (current term ends October 2025)

Katie is an experienced IT professional who has spent 30 years in the industry, managing large teams across the world.

She holds non-executive roles at the Property Ombudsman, the Pensions Regulator and Manx Care, sitting on various committees, and she is a Fellow of the British Computer Society.

Katie has been a charity trustee and is heavily involved in sport, both participating and volunteering.

Appointed September 2018 (current term ends August 2027)

Gavin is Professor of Medicine and Head of the Medical Sciences Division, University of Oxford

He received his first degree from Cambridge in 1984 before moving to Oxford to complete his medical studies in 1987. He then completed training in general internal medicine and obtained a DPhil from Oxford University in 1998.

In 2004, Gavin was appointed to the Chair of Medicine at Hammersmith Hospital, Imperial College and became Dean of the Faculty of Medicine in 2015. He returned to Oxford as Head of the Medical Sciences Division in October 2017.

His research concerns the immunology of infectious diseases with an interest in dengue and Zika virus infections. He is a Fellow of both the Academy of Medical Sciences and the Royal College of Physicians, and was a Senior Investigator in the National Institute for Health Research.

Appointed December 2019 (current term ends November 2025)

Professor Schapira was appointed as a Consultant Neurologist at the Royal Free Hospital and the National Hospital for Neurology and Neurosurgery, Queen Square in 1988, and to the University Chair of Clinical Neurosciences at the University College London (UCL) Institute of Neurology in 1990.

His research interests focus on neurodegenerative disease, particularly Parkinson's and other movement disorders.

He is the principal investigator on the Medical Research Council and EU H2020 programmes for neurodegenerative diseases.

During his career he has won a number of awards for his research, and was elected a Fellow of the Academy of Medical Sciences in 1999.

Professor Schapira was a Non-Executive Director of Royal Free London NHS Foundation Trust from 2009 to 2020; he chaired the Trust's Clinical Standards and Innovation Committee and was a member of the Remuneration Committee.

He also has extensive Board experience in the broader public sector including as a Non-Executive Director on the Board of the Ministry of Justice, Office of the Public Guardian from 2012 to 2018 and as a current member of the NHS Independent Reconfiguration Panel.

Appointed April 2021 (current term ends April 2027)

Ash studied Pharmacy at Portsmouth School of Pharmacy and, after graduating in 1983, he began his Pharmacy career in Central London and opened the first of his three pharmacies in 1986.

In early 2004, he was one of the first pharmacists to qualify as a supplementary prescriber and he qualified as an independent prescriber in June 2007.

Ash has been Chair of the National Pharmacy Association's Board, is a past President, Assembly and English Pharmacy Board Member of the Royal Pharmaceutical Society, and is a former Vice President of the International Pharmacy Federation.

Ash is currently President of the National Association of Primary Care, and Non-Executive Director of Sussex Integrated Care Board (ICB) and Chair of its Subcommittee for Workforce and Remuneration.

He has held a number of roles with Lambeth Clinical Commissioning Group, including Clinical Network Lead and Professional Executive Committee Chair, and has received an OBE for Services to Pharmacy and the NHS.

Appointed June 2021 (current term ends May 2027)

Joy is the CEO of brap, a national equalities and human rights charity. Her area of expertise is leadership and organisational development and she applies this lens to the work that brap does with organisations, boards and leadership teams.

Joy's background is in anti-discriminatory practice and application. Her expertise has been sought after and recognised on numerous occasions by the Department of Health, Cabinet Office, Department of Education, Care Quality Commission and others.

As a lifelong learner, Joy has an MSc in Organisational Development and Learning, a Certificate in Education PGCE, a Postgraduate Diploma in Multicultural Education, and a Certificate in Process Work (from the Deep Democracy Institute - Oregon).

Joy is a member of the NHS Leadership Faculty and currently delivers a range of inclusive leadership programmes, including the Stepping Up leadership development programme for aspiring black, Asian and Minority Ethnic (BAME) colleagues in the health sector.

She is also a Visiting Professor at Middlesex University.

Appointed September 2024

Ben, who has spent the past 25 years in clinical training and practice with 10 years of experience as a Consultant in Intensive Care and Anaesthesia, joined the Trust as Divisional Director for Clinical Support Services (CSS) in March 2022 and took up the post of Chief Digital and Information Officer (CDIO) on 14 October 2024.

During his career he has developed expertise in not only the use of digital technology to transform patient care but also senior medical management and leadership.

Before joining OUH he was Chief Clinical Informatics Officer and Associate Medical Director for Technology and Transformation at South Warwickshire NHS Foundation Trust.

In his role as CDIO, Ben will lead the use and adoption of new digital technologies and approaches including AI, in order to enhance the working lives of colleagues and improve patient experience.

Appointed August 2023

Andrew has been a Consultant in Infectious Diseases and Medicine at Oxford University Hospitals since 2015. He was Clinical Lead for Infectious Diseases at OUH from 2018 to 2021, and then Deputy Chief Medical Officer and Director of Clinical Improvement from 2021 to 2023, prior to his appointment as Chief Medical Officer. He remains an Honorary Senior Clinical Lecturer at the University of Oxford.

Andrew was regional clinical lead for sepsis and deterioration for the Oxford Academic Health Sciences Network (AHSN) from 2016 to 2023 and has contributed to national studies and task and finish groups for both sepsis and COVID-19.

He has a Masters in Epidemiology and a Postgraduate Diploma in Learning and Teaching in Higher Education and has been an examiner for the University of Oxford and the Royal College of Physicians.

Appointed December 2023

Yvonne joined the Trust on 1 May 2024 from Milton Keynes University Hospital NHS Foundation Trust, where she was also Chief Nursing Officer.

She was previously Deputy Chief Nursing Officer at Norfolk and Norwich University Hospitals NHS Foundation Trust.

Appointed October 2016

Jason is a graduate of the University of Oxford, where he completed a Doctorate in Modern History.

His extensive career experience includes three years as the Deputy Finance Director at University College London Hospitals NHS Foundation Trust, and roles within HM Treasury and major audit and professional services companies.

He was previously the Director of Finance, Reporting and Risk at the foundation trust regulator, Monitor.

Appointed July 2023

Mark Holloway joined the Trust in September 2023 from Bradford Teaching Hospitals NHS Foundation Trust, where he was Executive Director of Estates and Facilities.

Mark is a qualified building services engineer whose previous roles include Director of Estates and Facilities at Birmingham Community Healthcare NHS Foundation Trust.

He has a track record of leading transformational programmes to create the best possible environments to improve both patient and staff experience.

Appointed November 2019

Terry joined the Trust in February 2020 from The Hillingdon Hospitals NHS Foundation Trust, where he was Director of People and Organisational Development.

Prior to this role he was Director of Workforce at Kingston Hospital NHS Foundation Trust and Associate Director of HR at Barts Health NHS Trust.

He has held a number of other senior HR positions in NHS trusts, as well as being seconded to NHS England as Joint Director of Equality and Inclusion.

Terry is a Fellow of the Chartered Institute of Personnel and Development (CIPD), has completed the Top Manager Programme with the King's Fund, and is a certified Coach and Mediator.

Appointed June 2024

Felicity joined the Trust on 28 October 2024 from Great Western Hospitals NHS Foundation Trust where she was Chief Operating Officer.

She was previously Deputy Chief Operating Officer and Divisional Director for Surgery at Gloucestershire Hospitals NHS Foundation Trust.

Felicity has a strong track record of leading teams in delivering clinical services and standards, so that patients receive high quality treatment in the most appropriate care setting in a timely way.

She also has a clear passion for integration of services across organisational barriers, in order to improve care pathways for patients.